HomeClinical TopicsCardio-PulmonaryFDA approves Corlanor for treatment of heart failure

FDA approves Corlanor for treatment of heart failure

On April 15, the U.S. Food and Drug Administration (FDA) approved Corlanor (ivabradine) to reduce hospitalization from worsening heart failure. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content